P-97 Updated results of HGCSG1603: A phase 2 trial of ramucirumab plus irinotecan combination therapy as second-line treatment for patients with advanced gastric cancerM. Nakamura, Y. Kawamoto,S. Yuki,K. Sawada,O. Muto,S. Sogabe,Y. Shindo,A. Ishiguro,A. Sato,Y. Tsuji,M. Dazai,H. Okuda,T. Sasaki,K. Harada,H. Nakatsumi, K. Iuchi,Y. Sakata, Y. KomatsuAnnals of Oncology（2021）引用 0|浏览25暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
